CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.